HB Tempcon Expands Global Biopharma Logistics with New International Route

Haier Biomedical's HB TempCon reefer container has launched international routes, entering the global market and providing secure transportation for biopharmaceutical products, leading the industry's development. This expansion ensures temperature-sensitive biological materials are safely transported across borders, meeting the growing demand for reliable cold chain logistics in the biopharmaceutical sector. The move signifies Haier Biomedical's commitment to innovation and its ambition to become a key player in the global temperature-controlled transportation market.
HB Tempcon Expands Global Biopharma Logistics with New International Route

When precious biopharmaceutical products cross international borders, temperature stability becomes a critical lifeline. Imagine life-saving vaccines or targeted therapies traversing thousands of miles through complex supply chains while maintaining precise temperature parameters—this requires cutting-edge technology and specialized expertise.

Global Expansion: PVG-FRA Route Marks International Milestone

HB TempCon, a subsidiary of Haier Biomedical, has recently achieved a significant milestone with the successful inaugural flight of its active temperature-controlled RKN container aboard China Southern Airlines CZ463 cargo flight from Shanghai Pudong Airport (PVG) to Frankfurt Airport (FRA). This follows the company's earlier accomplishment of establishing regional "PVG-TPE" routes.

The international route launch represents a strategic expansion in HB TempCon's global network, demonstrating its capability to deliver reliable temperature-controlled logistics services worldwide. During the PVG-FRA operation, the RKN container's operational simplicity and superior temperature performance earned high praise from partners and clients alike.

RKN Container: Precision Technology for Critical Shipments

At the core of HB TempCon's offering is its proprietary RKN container system, an active temperature-controlled unit featuring:

  • Precision Control: Advanced technology maintains exact temperature parameters for diverse biopharmaceutical products
  • Uncompromising Reliability: Consistent performance across varied transport conditions
  • Intuitive Operation: User-friendly design minimizing training requirements
  • Real-time Monitoring: Continuous tracking of temperature, humidity with data logging and alert systems
  • Global Compliance: Meets all IATA standards for international air transport

Market Growth: Surging Demand for Temperature-Sensitive Logistics

The global biologics market, valued at $268.5 billion in 2021, is projected to reach $420.6 billion by 2025, growing at a 12% CAGR. This expansion, coupled with a 40% increase in air-shipped biologics between 2019-2021, has created unprecedented demand for specialized cold chain solutions.

Global Network: Comprehensive Coverage Across Key Hubs

HB TempCon has established operations at major international airports including:

  • Chicago O'Hare (ORD)
  • Los Angeles (LAX)
  • Frankfurt (FRA)
  • Amsterdam Schiphol (AMS)
  • Shanghai Pudong (PVG)

The company continues to expand its aviation, operational and maintenance networks to provide end-to-end temperature management solutions across all required ranges.

Comprehensive Solutions for Critical Industries

HB TempCon's technology serves vital sectors including biopharmaceuticals (vaccines, blood products, diagnostics), specialty chemicals, precision electronics, and perishable foods. By ensuring temperature integrity throughout the supply chain, the company supports global health initiatives and technological advancement.

With its commitment to innovation and excellence, HB TempCon is positioned to lead the evolution of global temperature-controlled logistics, delivering reliable solutions for the world's most sensitive shipments.